Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

Abstract

MULTIPLE sclerosis is thought to be an autoimmune disease of the central nervous system mediated by T cells specific for a myelin antigen1,2. Myelin basic protein has been studied as a potential autoantigen in the disease because of its role as an encephalitogen in experimental autoimmune encephalomyelitis and post-viral encephalomyelitis3,4 and because of the presence in the blood of multiple sclerosis patients of in vivo-activated T cells reactive to myelin basic protein5. Immune involvement in multiple sclerosis has been further suggested by the association with the major histocompatibility complex class II phenotype DR2, DQwl (refs 6–9). To define the T-cell specificity toward myelin basic protein, 15,824 short-term T-cell lines were established from multiple sclerosis subjects, subjects with other neurological diseases, and normal controls. Here we report a higher frequency of T-cell lines reactive with a DR2-associated region of myelin basic protein between residues 84–102 in patients with multiple sclerosis compared with controls. A second region, identified between residues 143–168, was recognized equally in multiple sclerosis patients and controls and was associated with the DRwll phenotype. These DR2 and DRw11 associations were also observed among T-cell lines generated from family members of a multiple sclerosis patient. The immunodominant 84–102 peptide from myelin basic protein was both DR2- and DQwl-restricted among different T-cell lines. These results raise the possibility that this immunodominant region may be encephalitogenic in some DR2+ individuals.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McFarlin, D. E. & McFarland, H. F. New Eng. J. Med. 307, 1183–1188 (1982).

    Article  CAS  Google Scholar 

  2. Hafler, D. A. & Weiner, H. L. Immun. Today 10, 104–107 (1989).

    Article  CAS  Google Scholar 

  3. Alvord, E. C., Kies, M. W. & Suckling A. J. (eds) in Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis (Liss, New York, 1984).

  4. Hafler, D. A., Benjamin, D. S., Burks, J. & Weiner, H. L. J. Immun. 139, 68–72 (1987).

    CAS  PubMed  Google Scholar 

  5. Allegretta, M., Nicklas, J. A., Sriram, S. & Albertini, R. J. Science 247, 718–721 (1990).

    Article  ADS  CAS  Google Scholar 

  6. Ho, H.-Z., Tiwari, J. L., Haile, R. W., Terasaki, P. I. & Morton, N. E. Immunogenetics 15, 509–517 (1981).

    Article  Google Scholar 

  7. Spielman, R. S. & Nathenson, N. Epidemol. Rev. 4, 45–65 (1982).

    Article  CAS  Google Scholar 

  8. Francis, D. A., Batchelor, J. R., McDonald, W. I., Hern, J. E. C. & Downie, A. W. Lancet i, 211 (1986).

    Article  Google Scholar 

  9. Elian, M. et al. Disease Markers 5, 89–99 (1987).

    CAS  PubMed  Google Scholar 

  10. Brinkman, C. J. J. et al. Ann. Neurol. 11, 450–455 (1981).

    Article  Google Scholar 

  11. Johnson, D. et al. J. Neuroimmun. 13, 99–108 (1986).

    Article  CAS  Google Scholar 

  12. Brod, S. A., Purvee, M., Benjamin, D. & Hafler, D. A. Cell. Immun. 125, 426–436 (1990).

    Article  CAS  Google Scholar 

  13. Waksman, B. H., Porter, H., Lees, M. B., Adams, R. D. & Folch, J. J. exp. Med. 100, 451–471 (1954).

    Article  CAS  Google Scholar 

  14. Yoshimura, T. et al. J. neurol. Sci. 69, 47–58 (1985).

    Article  CAS  Google Scholar 

  15. Baxevanis, C. N. et al. J. Neuroimmun. 22, 23–30 (1989).

    Article  CAS  Google Scholar 

  16. Antel, J. P., Arnason, B. G. W. & Medof, M. E. Ann. Neurol. 5, 338–342 (1979).

    Article  CAS  Google Scholar 

  17. Chofflon, M., Weiner, H. L., Morimoto, C. & Hafler, D. A. Ann. Neurol. 24, 185–191 (1988).

    Article  CAS  Google Scholar 

  18. Zamvil, S. et al. Nature 324, 258–260 (1986).

    Article  ADS  CAS  Google Scholar 

  19. Sakai, K. et al. J. Neuroimmun. 19, 21–32 (1988).

    Article  CAS  Google Scholar 

  20. Happ, M. P., Wettstein, P., Dietzschold, B. & Heber-Katz, E. J. Immun. 141, 1489–1494 (1988).

    CAS  PubMed  Google Scholar 

  21. Offner, H. et al. J. exp. Med. 170, 355–367 (1989).

    Article  CAS  Google Scholar 

  22. Vandenbark, A. A. et al. J. Immun. 135, 229–233 (1985).

    CAS  PubMed  Google Scholar 

  23. Schluesener, H. J. & Wekerle, H. J. Immun. 135, 3128–3133 (1985).

    CAS  PubMed  Google Scholar 

  24. Chou, F. C.-H., Chou, C.-J. J., Shapira, R. & Kibler, R. F. J. biol. Chem. 251, 2671–2679 (1976).

    CAS  PubMed  Google Scholar 

  25. Dupont, B. (ed) in Immunobiology of HLA (Springer, New York, 1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ota, K., Matsui, M., Milford, E. et al. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 346, 183–187 (1990). https://doi.org/10.1038/346183a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/346183a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing